HCPLive Network

Study Recommends Funding for Primary Care Extension Program

THURSDAY, March 28 (HealthDay News) -- The Primary Care Extension Program (PCEP) has the potential to transform primary care and needs to be funded, according to a study published in the March/April issue of the Annals of Family Medicine.

Robert L. Phillips Jr., MD, from the American Board of Family Medicine, in Washington, D.C., and colleagues explain how the PCEP, which was authorized but not funded by the 2010 Affordable Care Act, is critical to enhancing primary care effectiveness, integrating primary care and public health, and translating research into practice.

The researchers draw an analogy between how the Cooperative Extension Program of the U.S. Department of Agriculture sped the modernization of farming a century ago and how the PCEP could speed the transformation of primary care through local deployment of community-based Health Extension Agents. The authors call for $120 million in annual federal funding for the PCEP, with a target of $500 million for future appropriations, saying the PCEP could speed the transformation of primary care, integrating primary care with public health and translating research into practice. The urgency of these goals requires rapidly building the PCEP, the authors say.

"In conclusion, the rapid pace of change in health care demands that a PCEP be viewed as an essential, and not optional, ingredient for transformation of primary care and improvement of population health," the authors write.

Abstract
Full Text (subscription or payment may be required)



Further Reading
The US Food and Drug Administration approved the first generic version of AstraZeneca's heartburn blockbuster, Nexium.
Opioids can be effective in controlling back pain, but their use carries risk of complications, misuse, and abuse. Clinicians have to decide when it is a good idea to prescribe them and when it is not.
Cerebral microbleeds (CMBs) following a transient ischemic attack (TIA) may be a sign a patient is likely to have another stroke. All patients who have a TIA are at risk of a recurrence, but that risk can be modified by optimal treatment, Jae-Sung Lim, MD, MSc and colleagues report. In fact, 80% of those recurrences could be eliminated, Lim wrote in a study in JAMA Neurology. But that may not be the case with TIA patients who have CMBs
More Reading